These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 37501128)

  • 1. Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies.
    Bowden SJ; Doulgeraki T; Bouras E; Markozannes G; Athanasiou A; Grout-Smith H; Kechagias KS; Ellis LB; Zuber V; Chadeau-Hyam M; Flanagan JM; Tsilidis KK; Kalliala I; Kyrgiou M
    BMC Med; 2023 Jul; 21(1):274. PubMed ID: 37501128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of cervical intraepithelial neoplasia: the role of human papillomavirus.
    Cox JT
    Baillieres Clin Obstet Gynaecol; 1995 Mar; 9(1):1-37. PubMed ID: 7600720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
    Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
    Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
    Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
    J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions.
    Feng T; Cheng B; Sun W; Yang Y
    BMC Womens Health; 2023 Nov; 23(1):599. PubMed ID: 37957634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in Honduras.
    Velema JP; Ferrera A; Figueroa M; Bulnes R; Toro LA; de Barahona O; Claros JM; Melchers WJ
    Int J Cancer; 2002 Feb; 97(4):536-41. PubMed ID: 11802219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.
    Rodríguez AC; Schiffman M; Herrero R; Hildesheim A; Bratti C; Sherman ME; Solomon D; Guillén D; Alfaro M; Morales J; Hutchinson M; Katki H; Cheung L; Wacholder S; Burk RD
    J Natl Cancer Inst; 2010 Mar; 102(5):315-24. PubMed ID: 20157096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-infection with trichomonas vaginalis increases the risk of cervical intraepithelial neoplasia grade 2-3 among HPV16 positive female: a large population-based study.
    Yang M; Li L; Jiang C; Qin X; Zhou M; Mao X; Xing H
    BMC Infect Dis; 2020 Sep; 20(1):642. PubMed ID: 32873233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation, treatment, and outcomes associated with vaginal intraepithelial neoplasia: A retrospective study of 118 patients.
    Yu D; Qu P; Liu M
    J Obstet Gynaecol Res; 2021 May; 47(5):1624-1630. PubMed ID: 33754436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence.
    Frega A; Stentella P; De Ioris A; Piazze JJ; Fambrini M; Marchionni M; Cosmi EV
    Cancer Lett; 2003 Jul; 196(2):127-34. PubMed ID: 12860270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of cervical intraepithelial neoplasia in women infected with human immunodeficiency virus (HIV) with no evidence of disease at baseline: Results of a prospective cohort study with up to 6.4 years of follow-up from India.
    Joshi S; Muwonge R; Kulkarni V; Deodhar K; Mandolkar M; Lucas E; Sankaranarayanan R
    Int J Cancer; 2019 Mar; 144(5):1082-1091. PubMed ID: 30132840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we increase the cervical cancer screening interval with an HPV test for women living with HIV? Results of a cohort study from Maharashtra, India.
    Joshi S; Muwonge R; Kulkarni V; Mandolkar M; Lucas E; Pujari S; Sankaranarayanan R; Basu P
    Int J Cancer; 2023 Jan; 152(2):249-258. PubMed ID: 35852007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study.
    Louvanto K; Syrjänen KJ; Rintala MA; Grénman SE; Syrjänen SM
    Acta Obstet Gynecol Scand; 2011 Feb; 90(2):167-73. PubMed ID: 21241262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
    Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
    JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific human papillomavirus types and other factors on the risk of cervical intraepithelial neoplasia: a case-control study in Korea.
    Kim CJ; Lee YS; Kwack HS; Yoon WS; Park TC; Park JS
    Int J Gynecol Cancer; 2010 Aug; 20(6):1067-73. PubMed ID: 20683419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.
    Branca M; Costa S; Mariani L; Sesti F; Agarossi A; di Carlo A; Galati M; Benedetto A; Ciotti M; Giorgi C; Criscuolo A; Valieri M; Favalli C; Paba P; Santini D; Piccione E; Alderisio M; De Nuzzo M; di Bonito L; Syrjänen K
    Eur J Gynaecol Oncol; 2004; 25(6):689-98. PubMed ID: 15597844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.